- Includes enzyme, substrate, plates, and buffers
- For use with the trusted Transcreener ADP² Assay (Sold Separately)
- Easy-to-use and HTS-ready
- Screen & perform dose-response assays quickly in your lab
Is your plate reader compatible? Find out now!
Is your plate reader compatible? Find out now!
The Enzolution POLQ Helicase ATPase Assay System includes POLQ helicase (DNA polymerase theta) enzyme, substrate, assay plates, and buffers required for a POLQ enzymatic reaction. The Transcreener ADP Assay (sold separately), a far-red competitive assay designed for HTS and inhibitor dose-response measurements, measures ADP produced by ATP hydrolysis to determine POLQ activity.
POLQ is synthetically lethal with BRCA-1 and ATM mutations, and both the polymerase and ATPase activities are being targeted with small molecules for anti-cancer drug discovery. The Enzolution POLQ Assay System, when used with the Transcreener ADP Assay Kit, provides all reagents required to screen and profile POLQ inhibitors.
The Transcreener ADP Assay is not included in the Enzolution Assay System but is available for separate purchase through BellBrook Labs. For ADP assay ordering information, please view Transcreener ADP Assay. The Transcreener ADP Assay is available with an FP, FI, or TR-FRET configuration.
When purchasing the Enzolution Assay System, it is important to choose the assay system readout corresponding to the FP, FI, or TR-FRET configuration of your Transcreener ADP Assay Kit.
Enzolution Assay System includes enzyme, substrate, & buffers for the POLQ reaction. The Transcreener ADP Assay measures ADP produced.
| Enzolution POLQ FP & FI Assay System | ||||
|---|---|---|---|---|
| 1K | 10K | |||
| Component | Part# | Qty | Part# | Qty |
| Recombinant POLQ Helicase Enzyme, Active, Human | 2287 | 2 μg | 2289 | 20 μg |
| POLQ ssDNA, 40 μM | 2286 | 60 μL | 2288 | 600 μL |
| Enzyme Assay Buffer A, 10X | 2278 | 2 mL | 2281 | 20 mL |
| Corning 384-Well Black Assay Plates (#4514) | 2229 | 3-Pack (1,000+ Assays) | 2230 | 30-Pack (10,000+ Assays) |
| Enzolution POLQ TR-FRET Assay System | ||||
|---|---|---|---|---|
| 1K | 10K | |||
| Component | Part# | Qty | Part# | Qty |
| Recombinant POLQ Helicase Enzyme, Active, Human | 2287 | 2 μg | 2289 | 20 μg |
| POLQ ssDNA, 40 μM | 2286 | 60 μL | 2288 | 600 μL |
| Enzyme Assay Buffer A, 10X | 2278 | 2 mL | 2281 | 20 mL |
| Corning 384-Well White Assay Plates (#4513) | 2231 | 3-Pack (1,000+ Assays) | 2232 | 30-Pack (10,000+ Assays) |
| Component | Notes |
|---|---|
| Transcreener ADP Assay | Available for separate purchase through BellBrook Labs. View Transcreener ADP Assay to learn more. Choose the readout configuration (FP, FI, or TR-FRET) that is the best fit based on preference and plate reader compatibility. |
| Ultrapure Nuclease Free Water | Some deionized water systems are contaminated with nucleases that can degrade both nucleotide substrates and products, reducing assay performance. Careful handling and use of ultrapure water eliminates this potential problem. |
| Plate Reader | A multi-detection microplate reader configured to measure output of the ADP tracer is required. |
| Liquid Handling Devices | Use liquid handling devices that can accurately dispense submicroliter volumes into 384-well plates. |
The POLQ enzyme reaction is initiated by the addition of DNA substrate and ATP. After the enzyme reaction is completed, ADP detection reagents are added (Transcreener ADP2 Antibody and Tracer).
The Enzolution POLQ Assay System used with the Transcreener ADP Assay produces robust results amenable to HTS. Z’ measurement using optimized POLQ assay conditions (n=12). Z’ = 0.93.
Conversion of raw data to ADP formed using a standard curve demonstrates assay linearity. Here, we use 50 µM ATP with 100 nM POLQ ssDNA substrate. The enzyme buffer included 50 mM Tris (pH 7.5), 1 mM MgCl2, and 0.01% Triton. The POLQ enzyme reaction took place for 60 minutes at 30°C. The ADP Detection Mix included 1X Stop & Detect Buffer B, 4 nM ADP2 Alexa Fluor 633 Tracer, and 55 µg/mL ADP antibody. The Detection Mix was added and incubated for 60 minutes at room temperature.
Transcreener Assays are designed for screening compound libraries in a high throughput format. Follow-up SAR can also be performed using the assay to determine inhibitor potency with ease. Here, 1280 compounds were screened from the Tocris 2.0 Library set using the Transcreener ADP2 FP Assay. Assay conditions included 0.5 nM POLQ helicase, 50 μM ATP, 100 nM 30-bp-ssDNA oligomer, 50 mM Tris, 1 mM MgCl2, 0.01% Triton (pH 7.5), 1X Stop & Detect Buffer B, 4 nM ADP2 AlexaFluor 633 Tracer, and 55 μg/mL ADP2 Antibody.
Choose the readout configuration that is the best fit for your lab based on preference and plate reader compatibility.
FI Detection Mix (10 μL): 1X Stop & Detect Buffer B, 50 μg/mL ADP2 Antibody-IRDye QC-1, 8 nM ADP2 AlexaFluor 594 Tracer.
TR-FRET Detection Mix (10 μL): 1X Stop & Detect Buffer C, 8 nM ADP2 Antibody-Terbium Conjugate, and 500 nM ADP HiLyte647 Tracer.
The Transcreener® ADP2 Assay is a far-red, competitive assay that measures ADP production to determine enzymatic activity. The technology uses a simple but highly effective method that consists of an antibody selective to ADP over ATP and a far-red fluorescent tracer. ADP produced in the reaction competes with the tracer, changing the fluorescent properties and providing a fluorescent readout.
The Transcreener® assay is designed specifically for high-throughput screening (HTS), with a single addition, mix-and-read format. It offers reagent stability and compatibility with commonly used multimode plate readers. The assay is available as an FP, FI, or TR-FRET configuration.
Active, human DNA polymerase theta enzyme (AA 67-894), C-terminal 6xHis-tagged protein expressed and purified from insect cells. The enzyme has been thoroughly validated with the Transcreener ADP Assay Kit. For specific activity, please refer to the Certificate of Analysis for each individual enzyme lot. Purity is >90% in a composition of 20 mM HEPES, 5 mM NaCl, 5% Glycerol, and 0.5 mM TCEP (pH 7.5). Currently used with the Transcreener assay at a concentration of 0.42 nM in a 10 μL reaction.
Interested in moving your program forward with BellBrook’s POLQ assay services? BellBrook scientists will use their extensive biochemistry and enzymology expertise to work with you and accelerate your POLQ discovery program.
ATPase Profiling Services Include:
Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.
There is extensive crosstalk between the DNA damage response (DDR) pathways and innate immune pathways. Both the individual pathways and the interconnections between them are a focus for exciting new small molecule drug therapeutics that target cancers and debilitating autoimmune disorders. The Transcreener HTS Assay platform accelerates these efforts by providing a robust and easy-to-use biochemical assay to measure activity of key enzymes in the innate immune and DDR pathway.
In this guide, we provide an overview of the DDR and innate immune pathway, and describe Transcreener Assays and Assay Systems for key therapeutic targets. The enzyme targets discussed include:
POLQ helicase functions as an ssDNA-dependent ATPase that can unwind short DNA duplexes and displace replication protein A (RPA) from single-stranded DNA. It also acts as a scanning motor protein that searches for microhomologies in the break region, using the ssDNA break on the opposite side of the break as a template for DNA extension to fill the gap.
Normal adult tissues express low or no POLQ. However, it overexpresses in lung, stomach, breast, ovarian, small intestine, and colorectal cancers. In each of these tumor types, high expression of POLQ tightly correlates with decreased survival. Since an expanding range of cancers seems to become addicted to POLQ in response to the loss of more accurate DSB repair systems, there is an opportunity to extinguish such cancers by targeting POLQ. Clinical trials began with promising candidate therapeutics in early 2022.
Read more in this article from BellBrook Labs: Looking Ahead: POLQ in the Future of Immuno-Oncology
Find the right resources to help you get to your solution faster.
Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.
“Some CROs reserve their best teams for high profile customers. If you’re not right there with them you get less experienced teams… BellBrook understands enzyme kinetics, so it made that part of the project so much easier. The larger CRO didn’t seem to have the expertise we needed in this area.”
“The ADP assay is a great choice for measuring activity for any ADP-generating enzyme in both real time and endpoint formats. The universal detection system has been very useful for more challenging targets.”
“Excellent blend of simplicity & good science. Excellent technical support”
“The assay itself has good reproducibility and provides a clear readout on our enzyme activity. The most important piece, however, is the level of attention to our project and rapid turnaround time. The staff at BellBrook knows what they are doing.”
“The Transcreener AMP/GMP Assay is extremely straightforward to use and is very sensitive. In a UV-based enzyme assay I needed 1 µM enzyme to see a decent signal; however using the Transcreener AMP assay I only need 10 nM. Also, BellBrook Labs have been very helpful with the assay development. Their representative has been very willing to quickly help me get my assay up and running.”
“Through the process of developing and validating an assay for HTS applications, I generated a very nice data package of robust high quality data.”
BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400
info@bellbrooklabs.com
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: